These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34215889)

  • 1. Psychotropic Medication Adherence in Children and Adolescents.
    Verma S; Agrawal R
    South Med J; 2021 Jul; 114(7):388-394. PubMed ID: 34215889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivational interviewing: a tool for increasing psychotropic medication adherence for youth.
    Hamrin V; McGuinness TM
    J Psychosoc Nurs Ment Health Serv; 2013 Jun; 51(6):15-8. PubMed ID: 23814821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.
    Logan SL; Carpenter L; Leslie RS; Hunt KS; Garrett-Mayer E; Charles J; Nicholas JS
    J Autism Dev Disord; 2014 Nov; 44(11):2931-48. PubMed ID: 24929833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
    Marcus SC; Durkin M
    J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):480-9. PubMed ID: 21515197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness.
    Harpaz-Rotem I; Rosenheck RA
    Child Care Health Dev; 2006 Mar; 32(2):225-37. PubMed ID: 16441857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A theoretical approach to medication adherence for children and youth with psychiatric disorders.
    Charach A; Volpe T; Boydell KM; Gearing RE
    Harv Rev Psychiatry; 2008; 16(2):126-35. PubMed ID: 18415884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Adherence Among Children and Adolescents with Severe Mental Illness: A Systematic Review and Meta-Analysis.
    Edgcomb JB; Zima B
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):508-520. PubMed ID: 30040434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication use in US youth with mental disorders.
    Merikangas KR; He JP; Rapoport J; Vitiello B; Olfson M
    JAMA Pediatr; 2013 Feb; 167(2):141-8. PubMed ID: 23403911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-adherence to Psychotropic Medication Among Adolescents - A Systematic Review of the Literature.
    Häge A; Weymann L; Bliznak L; Märker V; Mechler K; Dittmann RW
    Z Kinder Jugendpsychiatr Psychother; 2018 Jan; 46(1):69-78. PubMed ID: 27925499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
    Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.
    Pullen SJ; Wall CA; Angstman ER; Munitz GE; Kotagal S
    J Clin Sleep Med; 2011 Dec; 7(6):587-96. PubMed ID: 22171196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neural effects of psychotropic medications in children and adolescents.
    Singh MK; Chang KD
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):753-71. PubMed ID: 23040900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
    Radigan M; Lannon P; Roohan P; Gesten F
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK.
    Alfageh BH; Man KKC; Besag FMC; Alhawassi TM; Wong ICK; Brauer R
    J Autism Dev Disord; 2020 Feb; 50(2):625-633. PubMed ID: 31724119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and Promises of Pediatric Psychopharmacology.
    Giles LL; Martini DR
    Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.